Landmark FDA approval of Cobenfy represents the first new class of drugs indicated to treat schizophrenia in decades.
FDA Approves Bristol Myers Squibb’s Cobenfy for Schizophrenia
You May Also Like
Where can I buy Tobacco-Free Nicotine products?
February 27, 2025
Ozempic 用於什麼？
February 26, 2025
Global Launch Strategies in the Current Political Climate
February 19, 2025
+ There are no comments
Add yours